Trailing-twelve-month (TTM) revenue is $2.02 Billion with a year-over-year growth of +5.00%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-27 | $504,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-23 |
| Q4 FY2025Period ended 2025-12-27 | $446,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-12 |
| Q1 FY2026Period ended 2026-03-28 | $558,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-23 |
| Q2 FY2026Period ended 2026-06-27 | $508,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-23 |
| TTM revenue | $2,016,000,000 |
Current P/S: $5,957,475,724 market capitalization ÷ $2,016,000,000 TTM revenue = 2.96x.
Market capitalization source: FMP quote. Quote observed 2026-10-02T19:40:01.000Z. Latest revenue period ended 2026-06-27.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-27): $508.00M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 18 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-02T19:40:43.261Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252025-12-27 · USD |
|---|---|---|---|---|
| Mobileye | $1.8B | $2.0B | $1.6B | $1.9B |
| Other Operating Segment | N/A | N/A | N/A | $39M |
| Other Segments | $26M | $34M | $41M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252025-12-27 · USD |
|---|---|---|---|---|
| CHINA | $472M | $640M | $424M | $428M |
| Czech Republic, Koruny | N/A | $50M | $55M | $59M |
| GERMANY | $268M | $353M | $269M | $297M |
$2.02B
$2.02 Billion
+5.00%
vs. $1.92B a year ago (TTM)
+14.43%
5 Year compound annual growth rate
1 Year
+5.00%
3 Year
+1.31%
5 Year
+14.43%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.89B | +$240.00M | +14.51% |
| 2024 | $1.65B | ($425.00M) | (20.44%) |
| 2023 | $2.08B | +$210.00M | +11.24% |
| 2022 | $1.87B | +$483.00M | +34.85% |
| 2021 | $1.39B | +$419.00M | +43.33% |
| 2020 |
TTM Growth
+5.00%
3-Year CAGR
+1.31%
5-Year CAGR
+14.43%
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-02T19:40:43.261Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| HUNGARY | $87M | $94M | $76M | $85M |
|---|
| KOREA, REPUBLIC OF | $115M | $164M | $219M | $192M |
|---|
| POLAND | $69M | $97M | $82M | $110M |
|---|
| PORTUGAL | N/A | N/A | $26M | N/A |
|---|
| Rest of World | $61M | $73M | $82M | $72M |
|---|
| Singapore | N/A | $21M | N/A | N/A |
|---|
| SLOVAKIA | N/A | N/A | N/A | $88M |
|---|
| UNITED KINGDOM | $221M | $150M | $117M | $117M |
|---|
| UNITED STATES | $551M | $437M | $304M | $416M |
|---|
| $967.00M |
| +$88.00M |
| +10.01% |
